Acyl coenzyme A:cholesterol acyltransferase inhibition: potential atherosclerosis therapy or springboard for other discoveries?

Author： Heinonen Therese M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.11, 2002-11, pp. : 1519-1527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on the role of acyl-CoA:cholesterol acyltransferase inhibitors in atherosclerosis

By Wu Justina   Fishelevich Rita   Rodriguez Annabelle   Doshi Rajiv  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1655-1662

Informa Healthcare

Access to resources Recommend Favorite

Predicting Acyl-Coenzyme A: Cholesterol O-Acyltransferase Inhibitory Activity: Computational Approach Using Topological Descriptors

By LATHER VINEY   MADAN A. K.  

Drug Design and Discovery, Vol. 18, Iss. 4, 2003-01 ,pp. : 117-122

Taylor & Francis Ltd

Access to resources Recommend Favorite

Novel aryloxyalkylthioimidazoles as inhibitors of acyl-CoA: cholesterol-O-acyltransferase

By Bani M.   Bormetti R.   Ceccarelli W.   Fiocchi R.   Gobetti M.   Lombroso M.   Magnetti S.   Olgiati V.   Palladino M.   Villa M.   Vanotti E.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 1, 1995-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy

By Jukema J Wouter   van der Hoorn José WA  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 459-468

Informa Healthcare

Access to resources Recommend Favorite

Reversing the Paradigm for Atherosclerosis Therapy: The Potential of HDL Therapeutics

By  

Pharmaceutical Innovation, Vol. 11, Iss. 6, 2002-10 ,pp. : 21-24

Adis International

Access to resources Recommend Favorite